Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Alzheimer Drugs Market


6. Market Share – Alzheimer Drugs Market

6.1 By Drug Class
6.2 By End User
6.3 By Region


7. Drugs Class – Alzheimer’s Drug Market

7.1 Donepezil
7.2 Galantamine
7.3 Rivastigmine
7.4 Memantine
7.5 Others


8. End User – Alzheimer’s Drug Market

8.1 Hospital
8.2 Clinics
8.3 Nursing Home
8.4 Home Care Setting


9. Region – Alzheimer’s Drug Market

9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Rest of World


10. Key Players Analysis

10.1 Sanofi SA

10.1.1 Overview
10.1.2 Recent Development
10.1.3 Net Sales

10.2 F. Hoffmann-La Roche Ltd

10.2.1 Overview
10.2.2 Recent Development
10.2.3 Net Sales

10.3 Pfizer Inc

10.3.1 Overview
10.3.2 Recent Development
10.3.3 Net Sales

10.4 Abbott

10.4.1 Overview
10.4.2 Recent Development
10.4.3 Net Sales

10.5 Bayer AG

10.5.1 Overview
10.5.2 Recent Development
10.5.3 Net Sales

10.6 Merck & Co.Inc

10.6.1 Overview
10.6.2 Recent Development
10.6.3 Net Sales

10.7 Boehringer Ingelheim GmbH

10.7.1 Overview
10.7.2 Recent Development
10.7.3 Net Sales

10.8 Glaxosmithkline Plc

10.8.1 Overview
10.8.2 Recent Development
10.8.3 Net Sales

10.9 Novartis AG

10.9.1 Overview
10.9.2 Recent Development
10.9.3 Net Sales

10.10 Eli Lilly and Company

10.10.1 Overview
10.10.2 Recent Development
10.10.3 Net Sales

10.11 Teva Pharmaceutical Industries Ltd

10.11.1 Overview
10.11.2 Recent Development
10.11.3 Net Sales



List of Figures

Figure-01: Global – Alzheimer Drugs Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Alzheimer Drugs Market (Billion US$), 2023 – 2027
Figure-03: Drugs Class – Donepezil Market (Million US$), 2018 – 2022
Figure-04: Drugs Class – Forecast for Donepezil Market (Million US$), 2023 – 2027
Figure-05: Drugs Class – Galantamine Market (Million US$), 2018 – 2022
Figure-06: Drugs Class – Forecast for Galantamine Market (Million US$), 2023 – 2027
Figure-07: Drugs Class – Rivastigmine Market (Million US$), 2018 – 2022
Figure-08: Drugs Class – Forecast for Rivastigmine Market (Million US$), 2023 – 2027
Figure-09: Drugs Class – Memantine Market (Million US$), 2018 – 2022
Figure-10: Drugs Class – Forecast for Memantine Market (Million US$), 2023 – 2027
Figure-11: Drugs Class – Others Market (Million US$), 2018 – 2022
Figure-12: Drugs Class – Forecast for Others Market (Million US$), 2023 – 2027
Figure-13: End User – Hospital Market (Million US$), 2018 – 2022
Figure-14: End User – Forecast for Hospital Market (Million US$), 2023 – 2027
Figure-15: End User – Clinics Market (Million US$), 2018 – 2022
Figure-16: End User – Forecast for Clinics Market (Million US$), 2023 – 2027
Figure-17: End User – Nursing Home Market (Million US$), 2018 – 2022
Figure-18: End User – Forecast for Nursing Home Market (Million US$), 2023 – 2027
Figure-19: End User – Home Care Setting Market (Million US$), 2018 – 2022
Figure-20: End User – Forecast for Home Care Setting Market (Million US$), 2023 – 2027
Figure-21: North America – Alzheimer Drugs Market (Million US$), 2018 – 2022
Figure-22: North America – Forecast for Alzheimer Drugs Market (Million US$), 2023 – 2027
Figure-23: Europe – Alzheimer Drugs Market (Million US$), 2018 – 2022
Figure-24: Europe – Forecast for Alzheimer Drugs Market (Million US$), 2023 – 2027
Figure-25: Asia Pacific – Alzheimer Drugs Market (Million US$), 2018 – 2022
Figure-26: Asia Pacific – Forecast for Alzheimer Drugs Market (Million US$), 2023 – 2027
Figure-27: Rest of World – Alzheimer Drugs Market (Million US$), 2018 – 2022
Figure-28: Rest of World – Forecast for Alzheimer Drugs Market (Million US$), 2023 – 2027
Figure-29: Sanofi SA – Global Revenue (Billion US$), 2018 – 2022
Figure-30: Sanofi SA – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-31: F. Hoffmann-La Roche Ltd – Global Revenue (Billion US$), 2018 – 2022
Figure-32: F. Hoffmann-La Roche Ltd – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-33: Pfizer Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-34: Pfizer Inc – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-35: Abbott – Global Revenue (Billion US$), 2018 – 2022
Figure-36: Abbott – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-37: Bayer AG – Global Revenue (Billion US$), 2018 – 2022
Figure-38: Bayer AG – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-39: Merck & Co.Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-40: Merck & Co.Inc – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-41: Boehringer Ingelheim GmbH – Global Revenue (Billion US$), 2018 – 2022
Figure-42: Boehringer Ingelheim GmbH – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-43: Glaxosmithkline Plc – Global Revenue (Billion US$), 2018 – 2022
Figure-44: Glaxosmithkline Plc – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-45: Novartis AG – Global Revenue (Billion US$), 2018 – 2022
Figure-46: Novartis AG – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-47: Eli Lilly and Company – Global Revenue (Billion US$), 2018 – 2022
Figure-48: Eli Lilly and Company – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-49: Teva Pharmaceutical Industries Ltd – Global Revenue (Billion US$), 2018 – 2022
Figure-50: Teva Pharmaceutical Industries Ltd – Forecast for Global Revenue (Billion US$), 2023 – 2027

List of Tables

Table-01: Global – Alzheimer Drugs Market Share by Drug Class (Percent), 2018 – 2022
Table-02: Global – Forecast for Alzheimer Drugs Market Share by Drug Class (Percent), 2023 – 2027
Table-03: Global – Alzheimer Drugs Market Share by End User (Percent), 2018 – 2022
Table-04: Global – Forecast for Alzheimer Drugs Market Share by End User (Percent), 2023 – 2027
Table-05: Global – Alzheimer Drugs Market Share by Region (Percent), 2018 – 2022
Table-06: Global – Forecast for Alzheimer Drugs Market Share by Region (Percent), 2023 – 2027